Planned Daewoong-HanAll Merger Hit By Union Protests
This article was originally published in PharmAsia News
Executive Summary
The planned acquisition of South Korea’s HanAll Biopharma by its bigger rival Daewoong Pharmaceutical has met a setback as unionized workers are HanAll protesting the plan, demanding compensation and job security amid concerns over the transaction.